Fertility and Sterility
Volume 94, Issue 5 , Pages 1799-1804 , October 2010

Chlamydia antibodies and self-reported symptoms of oligo-amenorrhea and hirsutism: A new etiologic factor in polycystic ovary syndrome?

This work was presented as a poster at the 43d European Association for the Study of Diabetes annual meeting, which was held on September 18–21, 2007, in Amsterdam.

  • Laure C. Morin-Papunen, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, University Hospital of Oulu, Oulu, Finland
    • Corresponding Author InformationReprint requests: Laure C. Morin-Papunen, M.D., Department of Gynecology and Obstetrics, PL 24, FIN 90029 OYS, Oulu, Finland (FAX: 358-8-3154310).
    • ,
  • Antoni J. Duleba, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, University of California Davis, Sacramento, California
    • ,
  • Aini Bloigu, B.Sc.

      Affiliations

    • Child and Adolescent Health and Wellbeing Unit, National Institute for Health and Welfare, Oulu, Finland
    • ,
  • Marjo-Riitta Järvelin, M.D., Ph.D.

      Affiliations

    • Child and Adolescent Health and Wellbeing Unit, National Institute for Health and Welfare, Oulu, Finland
    • Department of Epidemiology and Public Health, Imperial College London, London, United Kingdom
    • ,
  • Pekka Saikku, M.D., Ph.D.

      Affiliations

    • Institute of Diagnostics, Department of Medical Microbiology, University of Oulu, Oulu, Finland
    • ,
  • Anneli Pouta, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, University Hospital of Oulu, Oulu, Finland
    • Child and Adolescent Health and Wellbeing Unit, National Institute for Health and Welfare, Oulu, Finland

Received 22 June 2009 ,Revised 9 October 2009 ,Accepted 13 October 2009.

References 

  1. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J. 1999;138:S419–S420
  2. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843
  3. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387–1397
  4. Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation. 2001;103:1194–1197
  5. Schachter J. Pathogenesis of chlamydial infections. Pathol Immunopathol Res. 1989;8:206–220
  6. Saikku P. The epidemiology and significance of Chlamydia pneumoniae. J Infect. 1992;25:27–34
  7. Witkin SS. Immunological aspects of genital chlamydia infections. Best Pract Res Clin Obstet Gynaecol. 2002;16:865–874
  8. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2:983–986
  9. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38:1165–1174
  10. Kelly CC, Lyali H, Petrie JR, Gould GW, Connell JM, Sattar N. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2001;86:2453–2455
  11. Zhang YF, Yang YS, Hong J, Gu WQ, Shen CF, Xu M, et al. Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome. Endocrine. 2006;29:419–423
  12. Vgontzas AN, Trakada G, Bixler BO, Lin HM, Pejovic S, Zoumakis E, et al. Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea. Metabolism. 2006;55:1076–1082
  13. Tarkun I, Cetinarslan B, Turemen E, Canturk Z, Biyikli M. Association between circulating tumor necrosis factor-alpha, interleukin-6, and insulin resistance in normal-weight women with polycystic ovary syndrome. Metab Syndr Relat Disord. 2006;4:122–128
  14. Fenkci V, Fenkci S, Yilmazer M, Serteser M. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril. 2003;80:123–127
  15. Orio F, Palomba S, Cascella T, Di Biase S, Manguso F, Tauchmanova L, et al. The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:2–5
  16. Thomann R, Rossinelli N, Keller U, Tirri BF, De Geyter C, Ruiz J, et al. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome. Gynecol Endocrinol. 2008;24:199–204
  17. Fernandez-Real JM, Lopez-Bermejo A, Vendrell J, Ferri MJ, Recasens M, Ricart W. Burden of infection and insulin resistance in healthy middle-aged men. Diabetes Care. 2006;29:1058–1064
  18. Nabipour I, Vahdat K, Jafari SM, Pazoki R, Sanjdideh Z. The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cyomegalovirus, and herpes simplex virus 1: the Persian Gulf Healthy Heart Study. Cardiovasc Diabetol. 2006;5:5
  19. Rantakallio P. The longitudinal study of the northern Finland birth cohort of 1966. Paediatr Perinat Epidemiol. 1988;2:59–88
  20. Jarvelin MR, Sovio U, King V, Lauren L, Xu B, McCarthy MI, et al. Early life factors and blood pressure at age 31 years in the 1966 northern Finland birth cohort. Hypertension. 2004;44:838–846
  21. Wang SP, Grayston JT. Immunologic relationship between genital TRIC, lymphogranuloma venerum, and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophtalmol. 1970;70:367–374
  22. Paldanius M, Bloigu A, Alho M, Leinonen M, Saikku P. Prevalence and persistence of Chlamydiax pneumoniae antibodies in healthy laboratory personnel in Finland. Clin Diagn Lab Immunol. 2005;12:654–659
  23. Karinen L, Pouta A, Hartikainen AL, Bloigu A, Paldanius M, Leinonen M, et al. Association between Chlamydia trachomatis antibodies and subfertility in the Northern Finland Birth Cohort 1966 (NFBC 1966), at the age of 31 years. Epidemiol Infect. 2004;132:977–984
  24. Dowell SF, Peelind RW, Boman J, Carlone GM, Fields BS, Guamer J, et al. Standardizing Chlamydia Pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis. 2001;33:492–503
  25. Dandona P, Aljada A. A rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and atherosclerosis. Am J Cardiol. 2002;90:27G–33G
  26. Sjoholm A, Nystrom T. Inflammation and the etiology of type 2 diabetes. Diabetes Metab Res Rev. 2006;22:4–10
  27. Savage DB, Petersen KF, Shulman GI. Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension. 2005;45:828–833
  28. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol. 1999;19:972–978
  29. Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102:42–47
  30. Shroff R, Kerchner A, Maifeld M, Van Beek EJR, Jagasia D, Dokras A. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. J Clin Endocrinol Metab. 2007;92:4609–4614
  31. Shi Y, Murdin A, Raudonikiene-Mancevski A, Ayach BB, Yu Z, Fantus IG, et al. Chlamydophila pneumoniae inhibits differentiation of progenitor adipose cells and impairs insulin signaling. J Infect Dis. 2008;197:439–448
  32. Dhurandhar NV, Kulkarni PR, Ajinkya SM, Sherikar AA, Atkinson RI. Screening of human sera for antibody against avian adenovirus. Obes Res. 1997;5:464–469
  33. Atkinson RI, Dhurandhar NV, Bowen R, Israel BA. Evidence for an association of an obesity virus with human obesity at three sites in the United States. Int J Obes Relat Metab Disord. 1998;22:557
  34. Dart AM, Martina JL, Kay S. Association between past infection with Chlamydia pneumoniae and body mass index, low-density lipoprotein particle size and fasting insulin. Int J Obes Relat Metab Disord. 2002;26:464–468
  35. Karppinen J, Mikkonen P, Kurunlahti M, Tervonen O, Paldanius M, Vasari P, et al. Chronic Chlamydia pneumoniae infection increases the risk of occlusion of lumbar segmental arteries of patients with sciatica: a 3-year follow-up study. Spine. 2003;1:E284–E289
  36. Thjodleifsson B, Olafsson I, Gislason D, Gislason T, Jögi R, Janson C. Infections and obesity: a multinational epidemiological study. Scand J Infect Dis. 2008;40:381–386
  37. Holden RJ, Pakula IS. The role of tumor necrosis factor-alpha in the pathogenesis of anorexia and bulimia nervosa, cancer cachexia and obesity. Med Hypoth. 1996;47:423–438
  38. Wingood GM, DiClemente RJ, Harrington K, Davies SL. Body image and African American females' sexual health. J Womens Health Gend Based Med. 2002;11:433–439
  39. Taponen S, Ahonkallio S, Martikainen H, Koivunen R, Ruokonen A, Sovio U, et al. Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study. Hum Reprod. 2004;19:1083–1088
  40. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–47

 L.C.M.-P. has nothing to disclose. A.J.D. has nothing to disclose. A.B. has nothing to disclose. M.-R.J. has nothing to disclose. P.S. has nothing to disclose. A.P. has nothing to disclose.

 This study was funded by the Academy of Finland.

PII: S0015-0282(09)03883-7

doi: 10.1016/j.fertnstert.2009.10.021

Fertility and Sterility
Volume 94, Issue 5 , Pages 1799-1804 , October 2010

Article Tools

* Image Usage & Resolution